文献速递前列腺癌

BAUS根治性前列腺切除术审计2014/2015:术者与中心手术量的实践差异

The British Association of Urological Surgeons (BAUS) radical prostatectomy audit 2014/2015 - an update on current practice and outcomes by centre and surgeon case-volume.
PubMed 文献 · BJU Int · 2018-02-26

该研究基于BAUS数据平台,收录2014年1月1日至2015年12月31日期间179名术者在86个中心实施的13 920例根治性前列腺切除术,约占同期HES总例数的95%。结果显示大多数手术在高手术量中心及由高手术量术者完成,机器人辅助腹腔镜为最常见术式;高手术量术者pT2切缘阳性率较低,开放手术输血率与住院时间差异最明显。

要点

  • 机器人辅助腹腔镜为最常见术式,占65%;腹腔镜占23%,开放占12%。
  • 高手术量术者神经保留率57.3%,低手术量术者48.2%。
  • 高手术量术者pT2切缘阳性率13.6%,低手术量术者17.7%。

核心结论

  • 在高手术量中心及由高手术量术者实施的根治性前列腺切除术占比高,微创尤其是机器人辅助为最常见术式。
  • 高手术量中心和高手术量术者报告更高的扩大淋巴结清扫率与训练病例比例,高手术量术者pT2切缘阳性率更低。
  • 开放手术与微创术式相比,输血率和住院时间的差异最为明显。

研究设计与样本

  • 基于BAUS数据与审计平台的前瞻性登记审计,收录2014年1月1日至2015年12月31日179名术者在86个中心实施的13 920例根治性前列腺切除术。
  • 中心手术量按2年期间分类为高(>200)、中(100-200)、低(<100);术者手术量分为高(>100)和低(<100)。

主要发现

  • 2年期间每术者中位手术量63.5例,每中心中位164例;机器人辅助腹腔镜占65%,腹腔镜占23%,开放占12%。
  • 高手术量中心和高手术量术者以机器人辅助腹腔镜为主,分别占74.3%和69.2%;51.6%的患者在高手术量中心接受机器人辅助手术。
  • 高手术量术者神经保留率57.3%,低手术量术者48.2%;扩大淋巴结清扫在高手术量中心更常见(22.1%)。
  • 机器人辅助腹腔镜术后中位住院时间在高手术量中心最低(1天),开放手术在各手术量类别均为3-4天。
  • 机器人辅助腹腔镜pT2切缘阳性率为14.4%;高手术量术者13.6%,低手术量术者17.7%;开放手术输血率2.96-4.49%,微创术式0.25-2.41%。

临床怎么用

  • 解读结果时需注意其为登记数据,不能推断因果关系。
  • 高手术量中心与术者更常实施扩大淋巴结清扫和训练病例,高手术量术者pT2切缘阳性率更低。
  • 开放手术相比微创术式输血率更高、住院时间更长。

局限性

  • 作者指出本研究为登记数据,不能假设因果关系,解释差异时需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe contemporary radical prostatectomy (RP) practice using the British Association of Urological Surgeons (BAUS) data and audit project and to observe differences in practice in relation to surgeon or centre case-volume. PATIENTS AND METHODS: Data on 13 920 RP procedures performed by 179 surgeons across 86 centres were recorded on the BAUS data and audit platform between 1 January 2014 and 31 December 2015. This equates to ~95% of total RPs performed over this period when compared to Hospital Episode Statistics (HES) data. Centre case-volumes were categorised as 'high' (>200), 'medium' (100-200) and 'low' (<100); surgeon case-volumes were categorised as 'high' (>100) and 'low' (<100). Differences in surgical practice and selected outcome measures were observed between groups. All data and volume categories were for the combined 2-year period. RESULTS: The median number of RPs performed over the 2-year period was 63.5 per surgeon and 164 per centre. Overall, surgical approach was robot-assisted laparoscopic RP (RALP) in 65%, laparoscopic RP (LRP) in 23%, and open RP (ORP) in 12%. The dominant approach in high-case-volume centres and by high-case-volume surgeons was RALP (74.3% and 69.2%, respectively). There was a greater percentage of ORPs reported by low-volume surgeons and centres when compared to higher volume equivalents. In all, 51.6% of all patients in this series underwent RP in high-case-volume centres using robot-assisted surgery (RAS). High-case-volume surgeons performed nerve-sparing (NS) procedures on 57.3% of their cases; low-volume surgeons performing NS on 48.2%. Overall, lymph node dissection (LND) rates were very similar across the groups. An 'extended' LND was more commonly performed in high-volume centres (22.1%). The median length of stay (LOS) was lowest in patients undergoing RALP at high-volume centres (1 day) and highest in ORP across all volume categories (3-4 days). Reported pT2 positive surgical margin (PSM) rate varied by technique, centre volume, and surgeon volume. In general, observed PSM rates were lower when RALP was the surgical approach (14.4%) and when high-volume surgeons were compared to low-volume surgeons (13.6% vs 17.7%). Transfusion rates were highest in ORP across all centres and surgeons (2.96-4.49%) compared to techniques using a minimally-invasive approach (0.25-2.41%). Training cases ranged from 0.5% in low-volume centres to 6.0% in high-volume centres. CONCLUSIONS: Compliance with data registration for centres and surgeons performing RP is high in the present series. Most RPs were performed in high-case-volume centres and by high-case-volume surgeons, with the most common approaches being minimally invasive and specifically RAS. High-case-volume centres and surgeons reported higher rates of extended LND and training cases. Higher-case-volume surgeons reported lower pT2 PSM rates, whilst the most marked differences in transfusion rates and LOS were seen when ORP was compared to minimally invasive approaches. Caution must be applied when interpreting these differences on the basis of this being registry data - causality cannot be assumed.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Khadhouri S, Miller C, Fowler S, et al. The British Association of Urological Surgeons (BAUS) radical prostatectomy audit 2014/2015 - an update on current practice and outcomes by centre and surgeon case-volume. BJU Int. 2018. PMID: 29388311. doi:10.1111/bju.14156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。